Medtronic (MDT) Cash from Operations (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 23, 2026 | 196.65% |
| Oct 24, 2025 | -14.98% |
| Jul 25, 2025 | -56.96% |
| Apr 25, 2025 | -1.71% |
| Jan 24, 2025 | 168.48% |
| Oct 25, 2024 | -2.84% |
| Jul 26, 2024 | -64.49% |
| Apr 26, 2024 | 12.25% |
| Jan 26, 2024 | 274.28% |
| Oct 27, 2023 | -24.46% |
| Jul 28, 2023 | -64.43% |
| Apr 28, 2023 | 56.29% |
| Jan 27, 2023 | 70.72% |
| Oct 28, 2022 | -14.87% |
| Jul 29, 2022 | -47.35% |
| Apr 29, 2022 | -7.68% |
| Jan 28, 2022 | 25.95% |
| Oct 29, 2021 | 36.92% |
| Jul 30, 2021 | -25.96% |
| Apr 30, 2021 | -25.93% |
| Jan 29, 2021 | 26.60% |
| Oct 30, 2020 | 569.42% |
| Jul 31, 2020 | -80.83% |
| Apr 24, 2020 | -39.76% |
| Jan 24, 2020 | 28.92% |
| Oct 25, 2019 | 23.64% |
| Jul 26, 2019 | -27.65% |
| Apr 26, 2019 | 1.56% |
| Jan 25, 2019 | 76.70% |
| Oct 26, 2018 | -31.67% |
| Jul 27, 2018 | 63.97% |
| Apr 27, 2018 | -48.15% |
| Jan 26, 2018 | 120.73% |
| Oct 27, 2017 | 23.07% |
| Jul 28, 2017 | -58.43% |
| Apr 28, 2017 | -14.96% |
| Jan 27, 2017 | 41.64% |
| Oct 28, 2016 | -5.03% |
| Jul 29, 2016 | 16.89% |
| Apr 29, 2016 | -26.21% |
| Jan 29, 2016 | 40.50% |
| Oct 30, 2015 | 56.74% |
| Jul 31, 2015 | -57.32% |
| Apr 24, 2015 | 8.21% |
| Jan 23, 2015 | 93.54% |
| Oct 24, 2014 | 194.52% |